Ir para o conteúdo
Menu
Home
Quem Somos
Exames
Resultados
Certificações
Notícias
Seja Nosso Parceiro
(17) 3321-0344
Contato
Menu
Home
Quem Somos
Exames
Resultados
Certificações
Notícias
Seja Nosso Parceiro
(17) 3321-0344
Contato
Notícias
Saiba mais sobre nossos artigos científicos já publicados.
Clique e leia Estudos Colaborativos com a WHO
Câncer Hereditário
Medicina Personalizada
Selecione uma categoria
Câncer Hereditário
Medicina Personalizada
Assessment of Distributive DNA Methylation Profiling for Central Nervous System Tumor Classification Between Laboratories in the United States and Brazil
Clinical and molecular characterization of a large Brazilian lung cancer cohort: a real-world observational study
An integrated approach to molecular profiling supports precision diagnosis of pediatric medulloblastoma in Argentina amid the resource-constrained setting
Enhancing precision in sarcoma diagnosis- nCounter fusion panel implementation in a middle-income country
Implementation of the ProMisE classifier and validation of its prognostic impact in Brazilian endometrial carcinomas.
Brazilian patients who have never smoked- implications for targeted therapies
Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology
Somatic mutational profiling and clinical impact ofdriver genes in Latin-Iberian medulloblastomas-Towards precision medicine
Detection of NTRK fusions by RNA‐based nCounter is a feasible diagnostic methodology in a real‐world scenario for non‐small cell lung cancer assessment.
Painel Génico Preditivo de Resposta a ImunoTerapia em Câncer de Pulmão.
High frequency of WNTactivated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population.
Hospital de Amor de Barretos, SP, usa tecnologia avançada para tratar tumores
Exame é mais rápido e causa menos desconforto aos pacientes.
1
2
3
»